“Altered endocannabinoid (eCB) signaling is suggested as an important contributor to the pathophysiology of depression.
In summary, our data suggest a decreased eCB signalling in the FSL rats, which could contribute to the depressive-like behaviour.
Interestingly, the altered eCB system activity appear to be hemisphere-specific in the limbic regions.
Our study support the existing literature and showed altered eCB system activity in this particular animal model of depression.”
https://www.ncbi.nlm.nih.gov/pubmed/30716357
https://www.sciencedirect.com/science/article/abs/pii/S0197018618305151?via%3Dihub